Reaction Biology Announces New Epigenetic Production Facilities
News Apr 26, 2012
"The new facility expands our space by over 50%, and gives us the ability to greatly expand our production of epigenetic related proteins," remarked Dr. Haiching Ma, RBC Chief Technology Officer. "We will be able to accelerate growth of our list of available targets, and add space for new collaborations."
RBC simultaneously announced that it has expanded its available list of methyltransferase and related proteins to 27, and is continuing to add more. A number of the proteins are exclusive to RBC and cannot be found elsewhere. RBC now offers 25 HMT/DNMT's, including all of the human members of the important MLL/SET1 family of multi-protein complexes, along with 11 HDAC's, 4 SIRT's, 7 HAT's, and 12 DUB's.
The field of epigenetics is rapidly becoming the new focus of the drug-discovery and pharmaceutical industry. Epigenetic targets modulate gene expression, and have been indicated in a wide variety of diseases and conditions including cancer, inflammation, metabolic and neuropsychiatric diseases.
"The ability to selectively control gene expression is a holy grail for drug researchers. Drugs that successfully inhibit HMT or DNMT targets could be hugely effective," said Dr. Konrad Howitz, RBC Director of Epigenetics. "With the largest panel of such targets and proprietary high-quality proteins, we believe RBC could play a central role in this new research."
CRISPR Reveals New Targets for Promising Cancer DrugsNews
Novel screening method identifies new drug targets that could potentially enhance the effectiveness of PD-1 checkpoint inhibitors, a promising new class of cancer immunotherapy.READ MORE
BioAscent Announces New CEO and Plans to Expand Discovery Services OfferingNews
BioAscent Discovery Limited appoints new CEO, Paul Smith in preparation for the expansion of companies discovery services.READ MORE
Comments | 0 ADD COMMENT
EMBL Course: Next Generation Sequencing: RNA Sequencing Library Preparation
Apr 23 - Apr 27, 2018
EMBO Practical Course: Microbial Metagenomics: A 360º Approach
Apr 23 - Apr 30, 2018
EMBL Conference: European Conference of Life Science Funders and Foundations
Apr 19 - Apr 20, 2018
EMBL Course: Next Generation Sequencing: Whole Genome Sequencing Library Preparation
Apr 16 - Apr 20, 2018